Northfield Laboratories Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference to Be Webcast Live
October 28 2008 - 7:00AM
Business Wire
Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that
Steven A. Gould, M.D., Chairman and Chief Executive Officer, will
be presenting at the Rodman & Renshaw 10thAnnual Healthcare
Conference on Tuesday, November 11, 2008, at 3:15 p.m. ET.
Interested investors may access the live webcast of the
presentation at www.northfieldlabs.com. A replay of the
presentation will be available and will be archived for two weeks.
About Northfield Laboratories Northfield Laboratories is a leader
in developing a hemoglobin-based oxygen-carrying red blood cell
substitute. The initial indication we are seeking for our product
PolyHeme� is the treatment of life-threatening hemoglobin levels
when blood transfusion is indicated but red blood cells may not be
available, appropriate or acceptable. PolyHeme� is a solution of
chemically modified human hemoglobin that requires no
cross-matching and is therefore compatible with all blood types. It
has an extended shelf life in excess of 12 months. For further
information, visit http://www.northfieldlabs.com
Northfield labs (NASDAQ:NFLD)
Historical Stock Chart
From Jul 2024 to Aug 2024
Northfield labs (NASDAQ:NFLD)
Historical Stock Chart
From Aug 2023 to Aug 2024